Sibgat Choudhury

Sibgat Choudhury is an experienced professional in the field of clinical biomarker development, currently serving as Senior Director at Acrivon Therapeutics, Inc. since March 2021, after previously holding the position of Director in the same department. Prior to this role, Sibgat worked at Metamark Genetics from January 2012 to December 2015, where contributions included positions as Associate Director, Senior Research Scientist, and Research Scientist. Earlier experience includes a role as Senior Quality Control Officer at Beximco Pharmaceuticals Ltd. and a Research Fellow at DFCI/Harvard Medical School from January 2007 to January 2012. Academic credentials include a Ph.D. in Experimental Medicine from McGill University and a Master of Science in Biology (Molecular Biology) from Long Island University.